Nuwiq simoctogog alfa regulatory update

Health Canada approved Octaphama’s Nuwiq recombinant FVIII ( rFVIII) to treat and prevent bleeding in patients with hemophilia A. The rFVIII concentrate produced in a genetically modified human embry...